A Study of ASP4070 to Confirm Safety and Immunological Response in Patients With Pollen Allergy

NCT02469688 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Cedar Pollinosis

Interventions

DRUG: ASP4070
DRUG: Placebo

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]